Atrial Fibrillation and Stroke Prevention – What's New? episode artwork

EPISODE · Apr 23, 2026 · 10 MIN

Atrial Fibrillation and Stroke Prevention – What's New?

from ESO Voice of Stroke

In this episode of Voice of Stroke, we explore the latest evidence shaping stroke prevention in atrial fibrillation (AF) – a condition responsible for up to a quarter of all ischaemic strokes. This episode examines emerging strategies and unresolved questions in AF management, including: Whether left atrial appendage closure (LAAC) can replace anticoagulation in patients eligible for oral therapy The role of catheter ablation in reducing recurrent stroke risk after AF-related stroke New population data on blood pressure control and stroke risk, particularly in younger AF patients Key insights: Anticoagulation remains the cornerstone of stroke prevention, but limitations persist LAAC may reduce bleeding risk but does not yet clearly outperform anticoagulation in eligible patients Catheter ablation did not reduce recurrent stroke risk in current trial evidence Blood pressure is a critical—and potentially under-recognised—driver of stroke risk in AF, especially in younger populations Together, these findings refine how we approach AF stroke prevention, balancing procedural interventions, pharmacological therapy, and risk factor management. This episode was written by Voice of Stroke Podcast editor Umberto Pensato and Editor-in-Chief Linxin Li. Read the full transcript here. SHAPE \* MERGEFORMAT ----- References  Landmesser U et al. Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation. N Endl J Med. 2026; 394: 1270-1280. doi: 10.1056/NEJMoa2513310. https://www.nejm.org/doi/full/10.1056/NEJMoa2513310 Doshi SK et al. Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation. N Engl J Med. 2026 Mar 28. doi: 10.1056/NEJMoa2517213 https://www.nejm.org/doi/full/10.1056/NEJMoa2517213 Kimura K et al. Catheter Ablation and Oral Anticoagulation for Secondary Stroke Prevention in Atrial Fibrillation: The STABLED Randomized Clinical Trial. JAMA Neurol. 2026 Mar 2:e260155. doi: 10.1001/jamaneurol.2026.0155. https://jamanetwork.com/journals/jamaneurology/fullarticle/2845745 Jeong MH et al. Impact of blood pressure on the risk of stroke and all-cause mortality in patients with atrial fibrillation across different age groups: a nationwide population-based study. Heart Rhythm. 2026 Mar 24:S1547-5271(26)02172-7. doi: 10.1016/j.hrthm.2026.03.1917. https://www.heartrhythmjournal.com/article/S1547-5271(26)02172-7/fulltext  

Episode metadata supplied by the publisher feed · Published Apr 23, 2026

Embed this episode

Ready to play

Atrial Fibrillation and Stroke Prevention – What's New?

0:00 10:34

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of ESO Voice of Stroke?

This episode is 10 minutes long.

When was this ESO Voice of Stroke episode published?

This episode was published on April 23, 2026.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this ESO Voice of Stroke episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!